Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 17, 2009

National Jewish Health Accesses InterMune’s Idiopathic Pulmonary Fibrosis DNA Database

  • InterMune will collaborate with National Jewish Health investigators to help further the research of inherited genetic factors that may play a role in idiopathic pulmonary fibrosis (IPF).

    InterMune will provide researchers at National Jewish Health with access to DNA collected from patients who participated in the company’s Phase III trials in IPF for both pirfenidone and actimmune (interferon gamma-1b). The database includes DNA from approximately 1,500 IPF patients.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »